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Vitamin A, all-traIts-retinol, is metabolized to reti-
noic acid ill vivo by a tightly controlled two-step 
conversion. Retinoic acid then binds to nuclear re-
ceptors and modulates cellular proliferation and dif-
ferentiation. Because only a small fraction of retinol 
applied topically can be metabolized to retinoic acid, 
alternative pathways of retinol metabolism in skin 
were investigated. Retinol (0.4'!!0) was applied to adult 
human skin under occlusion for 6 h to 4 d. The 
conversion of retinol into various metabolites such as 
14-hydroxy-4,14-retro-retinol, anhydroretinol, 4-oxo-
retinol, retinyl esters, and retinyl glucuronides was 
investigated. The level of 14-hydroxy-retl'o-retinol 
was increased from undetectable at time 0 to 326 nglg 
wet weight of tissue at 6 h (6% of the retinol level) and 
maintained approximately the same concentration at 
24 h to 409 ng/g wet weight (1.9% of the retinol level); 
it decreased to 48 ng/g wet weight of tissue (12% , ofits 
T opica l application of retinoi c acid (RA) to adu lt human sIGn produced local erythema, increased epi-derma] thickl1es~ (Fishe r et (/ /, 1991), increased cellu-. lar retmOic aCId bmdll1g protem II (ellABI'JI) mlWA (Elder el (/ /, 1993) , and indu ced RA 4-hy-
droxylase activity (Duell e/ ai, 1992). These effects are thought to be 
mediated through RA binding to specific nuclear receptors, w ith 
subsequent transactivation of specific genes (Krus t el (/1, '1989). 
Application of lralts-reti nol (t-ROL) to ad ul t human skin produces 
many of these same efFects, except that no detectable erythenu or 
RA f0l"l11ation is observed (Kang el a/, 1.995). In keratin ocyte ce ll 
cultures, l- llOL is converted mainly to retinyl esters, with a small 
but detectable amount rnetaboljzed to RA (Kurlandsky et (// , 1994) . 
The small amount of I-RA can be quantitated. bec,lLIse in contrast 
to induction of the enzyme observed ;It 1);1)0 after (-ROL applica tion 
to skjn, RA 4-hydro~-yhlse is not inducible in cultured keratino-
cytes. In lymphocytes, oth er metabolites of r-ROL, such as 14-
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Inaximuln level) by 4 d. Anhyd.roretinol was unde-
tectable at tin'le 0, increased only slightly at 6 h, and 
remained at the same level. We did not detect 4-oxo-
retinol. Because 14-hydl'oxY-I,eu·o-retinol was found 
in the retinol-treated areas, its effects 011 epidermis 
were compared with those of retinol. Topical appli-
cation of trails-retinol (0.3%) significantly increased 
both epidermal thickness and cellular retinoic acid 
binding protein II mRNA, whereas 14-hydroxy-4,14-
I'etro-retillol (0.3'%) did not increase either of these 
well-characterized cutaneous retinoid responses. 
Retinol, when applied topically in pharmacologic 
doses to hun'lan epidermis, remained as free retinol, 
was metabolized primarily to retinol ester, and was 
Inetabolized to a lesser extent to retJ'O-retinoids and 
didehydroretinol. Key lVol'ds: J·etiny/ gillwrollidesldidelry-
dl'Ol'etil/ol/p/laI'llUlcolog},IIIIetaIJOlislll. J II/vest Damato/ 107: 
178-182, 1996 
hydroxy-4, 14-relro-retinol (14-HRR) (Buck ela/ , 1991 ; Eppinger cI 
ai, 1993; Derguini d ((/, 1994b), anhydro retino l (AR) (Buck el ai, 
1993; Eppinger 1'1 ai, 1993 ; Dcq~u ini el ai, 1994a), and 13 ,14-
dihydroxy-retinol (Derguini d a/, 1995), ha ve been shown to 
regulate proliferation, but not diffe rentiation. In this study, we 
investigated the formation and biologic ;lctiv ity of these compollnds 
in human epidermis. 
MATE I<"IALS AND METHODS 
Materials Retinoid sta nda rds purchased from Sigma C helnical Co. (St. 
Lo uis, MO) were as [allows: (-ROL, I('{/((s-retinaldehyde, (-ItA, l3-ri5-
I ~OL, 13-r;s-retinaldehyde. and J 3-c;s- ltA . The fo ll owing were gifts: 
4-hydroxy-RA.13-cis-4-oxo- LtA, 4-nxo-RA, 5,6-epoxy-RA. and Aft 
(from M. Rosenberger and P.l'. Sorter , Ho!l'mann Lal<..oche, Nutley. NJ) . 
and 9-cis-I~A (frol11 Drs. J. G ri ppo and A. Levin. Homnann Lal~oche) . Wc 
prepared 1 4- HIU~ according to Derguini ,,, 01 (1994b); 4-oxo-rctinol was 
obtained according to li terature procedures (13ochm C( aI , 1990). The retin yl 
esters (ROL esters) were gifts fi'o ll1 Dr. Anders Va hlqui st (Un ive rsity of 
Linkap ing. Sweden) and Dr. C hristine I-Iusclroll (HollinMlll LaRoche). 
tletilloyl glucuronide was a gift from Dr. Arun Bama (Un iversity of Iowa, 
Sioux C ity, IA) , 'I-c;s- retino yl glucuronide fi-om Dr. Jam O li ve r Sass (Freic 
Universitiit, Be rl in . Germany) . and I 3-r;s-retinoyl glucuronide from Holf-
mann La l~ochlO. All organ ic solvents for extractions and chrOIll"tography 
WlOre high-plOrforrnance liquid chromatograph)' (HI'LC) grade. HPLC was 
c"rricd out usin g a Hewlett Packard 1 090M C he", ·Work Station and a 
Sphcrisorb ODSI colullln ('1. (, 111111 X 2511 III 111) (Phase Separatiom. 
Norwalk , CT) to separate the rcti llo ids (Due ll ,'/ ai , 1992). T h e HPL 
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effi ue n t fl o wed directl y inl'o a Rad iomaric flow through scinti llation spec-
trOlTl e ter I\l1 odd 29SA to q ll ;] n litatl! recoveries. 
H unlan S u bjects a n d Biopsy P rocedu re In ad ul t volun tee rs, so lm io ns 
of ve hicl e (9 5':;', e rhano l:propylene glyco l. 7:3. v/v) , r-R O L. 14-H R.R . or 
I- I~ w e re app lied to the bu ttoc k area w ith occl usio n fo r vario us periods o r 
ti m e . B e fo re rem ova l o f ti ssue w irh a kera to l11 e. the area w as in ti ltra teel w ith 
1o/tJ lidoca illc . Areas \"ere tape stripped to r C l11 0VC str atllill co rn C Ulll and 
app li ed l11"te ria ls nor abso rbed into the viab le layers. A 4-111 111 p unch bio psy 
w as take n to ve rify the cO l11 plcte l1 e," o f the strip p ing proced ure as w el l as 
fo r dete rm ill ation o r c pide rma l t hickness by ro ll ti ll c li g ht histo logy. T he 
kera tol11e bi opsy spec inl ens werc ill1 l11 ed iate ly fj'ozen in liquiel nitroge n "nd 
sto red at - BO°C un ti l cx tracted . All su bjec ts gave writtc n consent to the 
p rotocol. approved by t he U ni versity o f Michig;m Institu tional K evic \\' 
Board . 
Extraction of Rctin oid s Extrac rio ll of t iss lI e to r the p resence o f re ti n -
oids was ca rri ed o ut w ith o rganic so lvents bn ta l1 o l:a('c to ni tr il e (1: I ) (M c-
C lean er ,d. 1982) . T he ti ss li e w as grou lld u lldcr liqu id ni trogen ill a mo rtar 
and pes tl e un til a !-i ll e powde r w as obtai ll ed . T he po wder was transl'C rrcd to 
a hOll1ogenize r cO ll ta illillg trace amo ullts o f r '\ H J I- I~ (to calcul ate recov-
e ri es) in o rgani c so lvellts at a r'lti o of 10: I (1111 so lve n t per g ,ve t w e ig h t 
tissue) . T he t i ~s u e w"s ho m ogeni zed with six to eig ht ~ n'okes of the pestl e 
and tra nsfe rred to a sc rew-cappeel g lass ce ll trifug" tube. T he sam p les we re 
vortcxed fo r 5 lIIill a ll d cell tr ifuged at 500 rpm fil l' 5 llI ill . T he o rgalli c phase 
was tra nsfe rred to a fi 'esh tu be . alld the re mailli ll g material w as re- e xtracred 
lI sing the san le proced ure. T'he cOlll i>i ll ed org al1i c p lt a :oi cs '''e re e vapo rated 
to d ryness u nd e r nitr oge ll alld resuspendcd in 200 f.L1 o f acetoni tr il e 
(M eCN) . T he sam ples we re fi lte red into H p LC vials. fo llo w ed by evapo-
n ltioll to d ryness and resuspe nsio n ill a fi nal vo lulll e o r 30 f.L1 o f MeC N. 
Re till o id s were separated 0 11 a Sphe riso rh O DS I reverse-phase co lumll with 
a grad ie ll t o f in creasillg MeCN concentrati o ll (Due ll 1'1 al . 1992). Sepa ratio n 
li lll C \-vas ex te Jl d ed fi 'O lll 4 2 Illi n to 110 ITlin \vitb a Ho w ra te in c rease fro lll 
0.5 11111m ill to 1 11I1 / l\1 ill at ~ O lII ill ro se para te and c lute retill yl es te rs fi'OI Il 
t he co lullln . 
Extraction of 14- HRR From E pidermis Epidermal strips i1-olll six 
ind ivid uals we re extracted w ith b uta ll o l: M eC N and pI' 'pa red fo r I-IP LC 
separatio n as d esc ri bed earlier. except that tracer R A was 1I0t presen t . 
Twell ty-fo ur aliq uots of the IIl ate rial Were illj ected 0 11 the H PLC . all d 
fracti o ll s We re co ll ected at 30-s illterva ls fro m 15 mill to 25 lIIill of the 
HPLC rUII . T he test tuhes contaillillg the peak elu ting at the elu tio n rime of 
authen ti c 14- HR.R were pookel . concen trated . a ll d analyzed by u ltn lvio le t 
(U V) absorp tio ll and mass spectroscopy. T he UV spectra w e re take n fro m 
rhe dio de aITa y co llto u r plo ts; the lo w-reso lu tio n e lectro ll impact lII ass 
spcctrlll11 a ll d rhe hi g h- reso lu t io n c lec tTo n ilnpac t Ill ass spcc trlll11 (refe re nce 
pcrAuo ro ke rosine) w ere m easurcd 0 11 a l EO L DX-3 03 H F spec trO lllete r 
UEO L U SA. IlI c .. Peabod y. M A) . 
Oth er Meth o d s PUll ch bio psy spec ill1 e ns w ere processed to r hem atoxy-
u n and co sill sra inillg alld w e re exam illed by light microscopy fu r epid ermal 
t b ickness . T he slides \Vcre read in a blinded fash ion w ith respect to 
O"catlll e nt gro u p . T he c pide n na l thi ckn ess in 111 ic r0 l11cte rs \Vas th e average 
of five Il lCaSUrCIll c n ts fi'o rn the bottOl1l o f the stra t u ll l CO n lCLlI11 to th e 
c pidc rnla l bast! lI lc nt I Il C lll bra ll e :1 t d iffe ren t int"e r- rete ridge sites. 
RNA iso la ti o n and q ualltitatio n of C R All I'll I11I1...N A we rc as desc ribed 
p rev io usly (Eld er cl al . 1993 ; J(;lIlg CI al. 1995) . Fo rry m icrogra lll s o f toral 
RNA w as lo"ded pCI' Ia nc, as dete rmined by 0 1) 2",,' 
Data w c re analyzed by e ither ti ,e Stude ll r's t test 1'01' paired da ta o r the 
repeated rll eaSlI rc s a n a lys is o f varian ce. All p values <l rc n .vo- sid cd . 
RES ULTS 
A OA'Yo 1-l1...0 L so lu tion in etha n o l:propy lcn e g lycol (7;3) w ith 0 .5 
mg bu ty lated h ydro xy to lu e n e (:I S a n an ti oxidan t) p e r tn l w as 
a pp li ed to ad ul t vo lu nteer s for 24 h unde r occlu s io n . o m po un d s 
ex tr ac te d fi'ol11 t h is site pro d u ced th e c h rom atog ra m sh own in F ig 
1. T h e n u mbe rs in di cate th e po in t in t h e separatio n w h e re sta n d a rd 
compo un d s e lu te d fro m th e column. As e x p e c te d , th e d o min an t 
p e ak was I- R O L. llecau se of iso l11 e ri z atio ll during p e n etratio n fi'o m 
th e surrrlc e to th e v iab le la ye rs o f t h e sk in . th e n e x t m os t p r o mine n t 
peak was 13-c;s R O L. rn add it io n , th ere w as a p romi n e n t un k n o wn 
peak t h at e lu ted a t 22 min a n d e x hibi te d " UV spec tru m w ith a n 
a bso rp tio n maximum a t 348 nm a n d a v ibratio n a l fi n e s tru cture 
id e ntica l to t hat of 14-HIU1... (Buc k d aI, 199 1; DCl'g ui ni ('I (I I, ·1994b) . 
I dentificatio n o f 14-HR R as a C o m p one n t in E pide rmal 
Extra c t To co nti I'm t he st ru c ture of thi s m etabo li te, fr ac ti o n s 
wel'e co ll e c ted fi'om n umerou s H P L C sepa ratio n s of extrac ts 
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Figu re L C h rom atogran, of epidermal extra c t obta ine d afte r ex-
pos u re of epide rlnis to 0.4%, tm us- retin ol unde r occlusion for 24 h. 
Epiden nal bio I'S), specilll en w as cx rractcd w ith butano l:acetoni trile ( I : I ). as 
desc ribed ill M all'rials a/l d iIlerl",r/s. Com pou nds we re separated hy I-JP LC 0 11 
a Sphe riso rb 0 1)S 1 col ul11l1 with incre"s illg M eC N . T he Ilulll be rs illdica te 
the rercntio ll t im es o f the fo llo willg sta lldards: I. 4-oxo-rcri llo l; 2. I ~­
hyd rox y-rerro-retill o l; 3. 13- r;.I'- rctill o l; 4. r-rc·tin o l; 5. allhydrOl-eri ll o l; 6. 
re t.inyl li no lcate; 7. retin yl o lea te ; 8. retill yl palllli rate. 
o bta in ed fro m I-R.OL-trc ate d epid e rmis. Figure 2 sh o w s th e 
reten tio n timc of a stan da rd so lution of I 4-H R __ R , and th e in se r t 
sh o w s th e su p e r imposed UV sp ectr a of t h e st anda rd and th e p ooled 
sa mp le . Co-i nj ectio n o f t h e stand a rd and e x t ra c te d m <lte ri a l gave a 
sin g le sh arp p e ak o n th e HPLC. 
Mass spectra l a n a lysis of th e p oo le d samp le is g iven in F i g 3. 
Both th e hi g h - resollllion (Fig 3A) and lo w-resolutio n (F ig 3B) 
mass sp ec tr a are in agreem e nt with th e li te rature (Buck 1'1 (I I. 199 1) ; 
i.e. , t h e o b se r ve d m ass of 302 .2244 (calcul a te d fo r C 21l H 3 /10 2 = 
302 .22'46) co n ti rms th at t h e n e w metabolitc w as ind eed 14 -HIUt as 
sugges ted b y th e UV spec tnllll a n d t h e HPLC retentio n rim c . T h e 
c irc u lar di c h ro ism spectrum (da ta n o r sh o wn) d id n ot sh ow o p tica l 
a c tiv ity, indica ti n g t h a t 14-HRR pro du ced unde r ph a rmacologic 
con ditions is a r acemi c mixtu re (D c r g u ini CI ai, 1994b ) . 
D a ta sh o w ing th e a m o u nt of 1 4 -H1U1... e xtracted /i'o m tissue a t 
t im e 0 and afre r a sin g le a p p li ca tio n o f O.4'Y.. I- R OL w ith specim ens 
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F ig u re 2 . C hrotnatogram obtained b y lllJ cction of a s t a nda rd 
solut io n of 14- h y droxy- 4 , 14-I'ell'o-rctinol (14-HRR) onto t h e HPLC. 
l1...e tell tio n ril11e of 14-I-JRR was 22 mill. wi th J-1PLC cOlld irions given in Fig 
L T he ;/15 1,,1 shows t1 w UV spectrum of the sta lldard (---) 'Illd the UV 
spectrum of the pooled peak ma tc ri,, 1 e~ t1·act.c d "i'0 111 rhe epidermis (- ). 
Figure 3. Mass spectl'a of pooled peak material extracted from 
retinol-treated epidermis . a) High-reso lution electron impact mass 
sp"ctrullI (m/e 302 .2244). II) l ow-resolutio ll ,,1cctro n impact mass spectrum 
(M ' 3(2) of the same eX!l'aned I 4-hydroxy-4 .1 4-)"('/nJ-retin ol ("I4-H!u\). 
Kctinoid extraction alldHPLC separatio n a, ill Fig 1. T he. pooled peak 
m;tte rial had a retention time and U V spec tnllll silldl :,,' to those of 14-I-IlU"t 
shown in Fig 2 . PFK , perHuorok"rosine. 
at 6, 24, and 96 h are giv en in Fig 4. We did not detect 14-HRH. 
at time O. T he concentrati o n of 14-H IU~ in nanograms per gram 
wet weight was simil ar at 6 h (326 ~ 73) and 24 h (409 ~ 107), but 
was markedl), reduced b)' 96 h (48 ~ 3) (m ea n ~ SEM) . In contrast, 
(-R.OL concentra tions reached a ma ximum at 24 h and re turn ed to 
6-h. leve ls at 96 h (Kang et aI, 1995). 
Topical 14-HRR Does Not Produce the Usual Retinoid 
Cuta neous Response T he effects of 14-HRR. on epiden11al 
pro life rnti o n and differentiation in compari son w ith the etrects of 
(-ROL and 1-llA were inv estigated usin g the 4-d patch tes t for 
clinical and histologic eva luati on . In ;lddieion, tape-stripped kera-
tome biopsy specimens were extracted to dete rmine pe ne trati o n of 
the applied compo und s in to the viable layers and to dete rmin e 
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Figure 4. Contellt of 14-hydroxy-4,14-rcll'O-retinol (14-HUR) in epi-
dermal extracts from epidertl1is treated with tralls-retino!. Epiderll1al 
biopsy specilllens were extracted and relin o ids were separated as in Fig l. 
C hanges in the nJJloums of 14-H IUl.. ex tracted fi 'om the epidermis at each time 
;Ire given :IS Ill ean :!:: SEM; 11 = S. VEH. vehicle . 
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Figure 5. R e tinoids extracted frOI11 viable epidermis 4 dafter 
application of 14-hydroxy-4,14-l'cll"O-retinol (14-HRR) and (I'aJ/S-
retinol (t-ROL). Either 0.3'10, 14-I-IIUl... 1) .3% I- Il..O l , or vehicle was 
applied to the " pidermis under occl usio n. Af-i:er ta pe strippin g to remOve the 
stratUlTl corne um and unabsorbed llIa(eri,t\ ". tissue was ex tracted with 
butallo l:MeCN. R.etinoids were separated as ill Fig 1. Data arc IIw all :!:: 
SEM; II = S. O pw /)(/)"s, vehicle; do.ml btlrs, 0.3% '\ 4-HIUl..; halelll',i l)(Irs. 0.3'1u 
I-ROL. ddRO L, didehydroretil1 o l; R O L este rs, retinyl es te rs. 
poss ibl e changes in the content of endogenous rcrino ids in the 
epid ermis as a result o f the applied compo unds. T he concell trations 
of I-RO L, 14-HRR, and R OL esters extrac ted from the tissue after 
applicatio n of O.3'!!', of each compound in eth,lllol:propylene g l}'col 
vehicl e are shown in Fig 5 . T he results showed th at 1 4-HlU~ 
penetrated into the viable layers of the epidermis (80 ± 23 ng/g wet 
weig ht; n = 5). T he 14-HRR-treated epid ermis, in comparison 
with vehicl e-treated tissue, contain ed the same amount of I-ROL, 
an increased amount (4 .7-fold) of ROL estcrs (40 ~ 20 ng/g wet 
weigh t; n = 5), and an incr'eased amo lln t (67')1,, ) of dd-ROL. In 
contra st, th e applica tion of 0.3')1" I-RO L in creased (-IlOL by 
3.7-fo ld (2499 ~ 428 ng/g wet we ight; n = 5), increased ROL 
esters 150-fo ld (1042 ± 304 ng rctin yl co mpo nent per g wet 
weight; n = 5), and in creased dd-R.OL 15-fold (48 ~ 18 ng/g wet 
weight; n = 5). T here was a small amount of 14-HR.R extracted at 
4 d (16 ::':: 8 ng/g wet weigh t; !l = 5). Th is is in agr'eement with the 
time-course data given previously (Fig 4) . Application of 0.025% 
1-1l0L, 14-HR.R, Ql- 1-IlA did not yie ld de tecta bl e amounts of 
14-HRR in the viable layers, and the r-ROL-treatcd sites sh owed 
on ly a 26'X, in crease in I - I~OL content above vehicle level s (data not 
shown). 
Epide rmal thi ckn ess was evahl<lted in hi sto logic section s fi'om 
punch biopsy specimens ta ken just be fo re keratome biopsi es. 
Neith er concentra t ion (0.3% o r 0 .025%) of 14-HRR altered epi-
de rmal thickness significantl y (p > O.OS), and on ly 0.3% (-ROL 
produced a signific<lnt (p < 0.05) increase in ep idermal thickness. 
simi lar to that o bserved w ith 0 .025% (-I"lA , as is shown in Fig 6 . 
In creased C R A BPli mR.N A in epidermis has been associated 
with in creased retinoic acid content of the epidermis, whi ch also 
alters ep idermal proliferation and d ifferen tiation (Elder er a/, 1993). 
Significant in creases in C llAJ3PII mRNA in comparison with 
vehicle were "oted in response to topica l appli catioll o f 0.()25% 
flA, 0 .025% (-ROL, o r 0.3% I-ROL (p < (l.05) , whereas neither 
cOll cen tra tion of 14-HRR in creased C RABPI I mltNA content in 
the epidennis, as is shown in Fig 7 . In data !lot shown, 14-HRJt did 
no t displace tritiated ligands from cellular retinol binding protein , 
C RABPI or II , or (ro l11 \luclear retino id receptors (personal con1-
JTlullication , Subhash Datta and Gar'), Fisher, Depar·tment of Der-
m atolog)" U lli versity o f Mi chi gan) . 
Other Retinol Metabolites The fo rmati on of All, a reversible 
inhibitor of 14-HIlR (Buck e/ aI, 1993; Derg uini el (Jf, 1994a), after 
applicatio n of I-ROL was also in vestigated . As shown in Fig 8 , the 
retenti o n time of a standard solution o f AR was 43 min. T he insert 
shows th e UV spectrum of sta ndard AR and the UV spectrum 
obta incd by diode arra y de tector of th c compound that elu ted at 
42 .9 min. T he amoun t of AR present ill th c extracts frolll th e 0.4% 
I-ROL-tl'e~ted tissue w~ s approximately 1% o f the 1 4-HIU~ levels 
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Figure 6. An increase in epidermal thickness was observed 4 dafter 
application of 0.3% t!'alls- retinol (ROL) but not 0.3 % 14-hydroxy-
4,14- I'etJ'o-retinol (14-HRR) , Each of the retinoids was applied in ethanol: 
propylene glycol (7:3) vehicle and occl uded for 4 d. Data are mean :': SEM; 
n = 8. ' Statistically significant difference (p < 0.05) between retinoic acid 
(RA) or retinol (ROL) and vchicle (VEI-I)-treated tissue. 
(Fig 1) and did not seem to vary during the 6-h to 4-d period. AR 
was not detected in vehjcle- treated areas. 
Recently, 4-oxo-ROL (a fill·ther metabolite of 4-0H-ROL) h '15 
been identified in extracts obtained from F9 ce lls trea ted first with 
t-RA. followed by addition of I-ROL as the cells are difFerentiating 
(Achkar el a i , 1996). T h e retentio n time and UV absorbance 
spectrum of a 4-oxo-ROL standard obtained by th e diode array 
detector of the HPLC are shown in Fig 9. Because the HPLC 
instrument captu res and stores the spectra of all compounds 
detected as peaks with absorbance in the range of 320 to 380 nm, 
the chromatograms obtain ed during this investigation were studied 
for the presence of m easurable quantities of 4-oxo-ROL. as 
assessed by its characte risti c spectrum . Although peaks oCCUlTed o n 
the chromatogra m s near the retention tim e of 4-oxo- ROL. the U V 
spectra were not compa tibl e with that of 4- oxo-ROL. Either 
4- oxo-ROL was n ot formed ;1/ JliJlo , was formed in too small a 
quantity to be detected, or was not stable to extrac tion conditions. 
Figure 10 summ,II'izes the possible routes of ROL m etabo lism . 
Possible pathw,lYS of conve rsio n oth e r tha n those descI'ibed in this 
s tudy are conversion of I-ROL to I-RA and formation of retinyl 
esters or g lu curonides. Fro m previous work, little o r n o detectable 
t-RA was extracted fi'om tisslIe treated ill JlitJo with I-ROL, but 
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Figure 7. CRABPII mRNA content of epidermis is increased 4 d 
after application of II'alls-retinol (ROL) but not after application of 
14-hydroxy-4,14-,'cll'/I-retinol (14-HRR). R.crinoids were app lied as in 
Fig 6. Isolation and identitication of mRNA are given in Material ... and 
Nlel/zoll .... Data are mean ± SEM: 11 = 8. ' Statistica lly significant difrerence 
(p < 0.05) between rc tinoic acid (RA). 0.025'10. retino l (ROL). or 0.3% 
ROL and vchicle-treated tissue. 
636 
474 
=> 
<I: 312 
E 
150 
RETINOL METABOLISM IN SKIN 181 
4~ 
Anhydroretinol 
AnhydroretInol 
••. UV · Standard 
_ UV · Extntctod 
900 J 368 9 
: i~ . 8 ~ :::~1 /ii i ~ 
: : 3 
225 ~ . 2 
, 1 
o : . 0 
33 0400405 
nm 
5 10 15 20 25 30 35 40 45 50 55 60 
minutes 
Figure 8. HPLC chromatogram of standard solution of anhydro-
retinol. Retention time of AR was determined by reverse phase chroma-
tography as in Fig 1. The iI/serf shows the UV spectrum of the standa.rd (- ... ) 
and the peak obtained in the epidermal extract (-). captured with the cliode 
array detector during elurjon of the standard and epidermal extract from the 
column. 
formation of retinyl esters was greatly increased (Kang el al. 1995) . 
To examine possible g lucuron idation of I-ROL, six extracts £i·ol11 
I-ROL-treated tissues were divided in h alf. Half was treated with 
l3- g lucuro nidase before separation by HPLC. There were no 
detectable changes ill the e lution p a tterns with l3-glucuronidase 
treatmen t, i.e ., no change in peak size or retention times , between 
treated and untreated samples. 
DISCUSSl ON 
In normal physiologic conditions. ROL is tran sported to ti sue 
bound to retinol binding protein (Soprano and Blaner. 1994) and 
sequestered in the cell by cellular retino l binding protein (Ong 1'1 aI, 
1994). Application of pharmaco logic doses of retinol to human skin 
circumvents this normal contro l and res ulted in increased leve ls of 
fi'ee ROL and in creased formation of retin yl esters in the epidermis 
(Kang CI al. '1995). Additional studies of ROL- treated skin have 
identified an unknown compound as 14-HRR based on chromato-
graphic retention time, UV spectrum. mass spectrum, and co-
e luti on with standard 14-H1~; 14-HRIl... was first iden tified in 
extracts from lymphocytes treated with ROL (Buck I't aI, 1991). 
Addition of pharmacologic amounts of ROL to lymphocytes in 
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F igure 9. HPLC chromatogram of standard solution of 4-oxo-
retinol. Retention time of 4-oxo-ROL was derermined with chromato-
graphic conditions as in Fig 1. T he ilw'I1 contains the UV spectrum captured 
with the diode array detecto r during elution of the standard. These data 
\ve re used to scan prev ioll s chr0l11atog rants obtained \vith ex-ente ts (i·oln 
treated skin for the presence of 4-oxo-ROL. 
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Figure 10_ Possible routes of retinol rnet"boli.<m in skin. Com-
pounds enclosed in sol ill lili es were extracted fi'o l11 epidermis treated with 
I-RO L; compo uods enclosed in dn shed lit,es were no t detected . but t lte ir 
fo rnwtion was inferred frol11 othe r data generated previously from human 
ski n o r kcratinocytes. No evidence for the fo rmarion of the other COI11-
pounds (unenclosed) was found. 4-0H-RA. 4-0H-rccinoic acid; LI ARAT. 
Icci thin/acyl:rctinol acyltransfc rasc; RAL. retinaldchyde: UDPGA. uridinc 
diphosphogl ucuronic acid . 
c ulture also produced a racemic mixture of 14-HIUz. (Derguini el 
aI, 1994b) , and this was observed in skin as well. Derguini cf nl 
(1994b) speculated tll<l t epoxidatio n of free ROL might occur in a 
nonste reospecific manner, w hereas epoxidation of ROL bound to 
irs specifi c binding prote in might occur in a stereospecifi c manner. 
O rig in all y, 14-HRJl... was identifi ed as an inducer of lymphocyte 
prol iferation (Buck ct nl, 1991) , and AR as a reversible inhibitor o f 
14-HRR effects (Buck ct al. 19(3) . A simi lar ro le for 14-HRR on 
kera til10cytcs should lead to increased epidermal thickness. In the 
4 -d patch tcst, O.3'V" 14-I-IRR did not increase epidermal thickness 
o r e rythe ma, which argues against J 4-HRR as an indu cer of 
prolifera tion in hum;m epidermis ill 11;"0. Because AR is a compet-
it ive inhibitor of 14-HKR (Buck ef ai, 1993). rhe sm ;l U ;1Il10 lU1t of 
AR present in the ep idermi s afte r ROL application wou ld not be 
suffi cient to antagonize l4-1-m .. R-induced pro life ration. T he lack 
of indll c tion o fClz.A.BPlI mltNA also indicates that 14-I-IIUz. is no t 
fUll c tioning as do o th er retinoids. such as f-RA and I-ROL, as bo th 
r e tino ids illduce mKNA for C Il..ABPll in human skin i,., "i,IO . T hus. 
th e function(s) of retro-retinoids present in epidermis remains 
unknown. 
Oth er known pathways of t-Il ... OL m etabo lism are 1-1l..A forma-
tion in keratinocytes (Kurlandsky l'i ai, '} 994), retinyl este rs (Torma 
a nd Vahlquis t. 1990; Ka ng cl ai, 1995), and dd-ROL (To rma and 
V ahlq\Jist, 1991). M e <l surable gLHlll tities of t-RA are rare ly found 
w hen (-ROL is app li ed to human skin ;11 II ; PO, even w ith subsequent 
ex traction of the tissu e for re tinoid content with organic solven ts 
c hlo roform :m ethanol (2 :1) and m.ethano l:water at pH 3 .2 (85: 15). 
T his is probably du e to the indu ction of I-RA 4-hydroxylase (Duell 
el ai, t ( 92 ), which prevents I-RA acculllulation. Addition of I-RA 
to ket atinocytes in culture docs not induce I-RA 4-hyd ro xylase 
activity. Both I-RAL and l-ll..A were iso lated from su ch cultures 
after th e addition of I-ROL. T he m eta bo lism of I-ROL to t -l~ was 
require d to demonstrate biologic activity (Kurlandsky el ai, 19(4). 
An in creasing g radient of R OL ester content in n ormal epidermis 
(r'om basa l layer to str<Jt um corn e um has bee n reported b y oth er 
in vesti.ga tors (Tormi\ and Vahlquist, 1990) . The R OL ester content 
o f epidermi s in th e ex periments repo rted here was som ew hat low 
becau se of l055 of the upper layers of epidermi s by tape strippingjust 
b efore bi opsy of the site. Ester formation, however, remains the 
main ro ute by whi ch epide rmal cells handl e excess /-ROL (Kang el 
ai, 1995 ). Som e conve rsi o n of t-ROL to dd-ROL was detected in 
t he f-'ROL-tre;\(ed tissues. which agrees with pre vio us reports of 
dd- R QL levels of 5-18(/"0 of f-RO L levels (Torma and Vahlquist, 
1991) .. T he I-ROL or dd-ROL le vels w ere uncl~anged or margin-
~ lI y ch~nged afte r treatm ent w ith 14-HRR. 
THE J O URNAL O F INVEST IGATIVE DERMATOLOGY 
T he fo rmatio n of g lucuronides is a poss ible m echanism for 
removing excess I-ROL ill the epidermi s. bu t /3-glu curo llidase 
treatment produced no chan ges in the chro matograms. It is ne ver-
th eless poss ibl e (hat g lu curo nides fo rllled in e pidermis ill "i, IO woul d 
be exported into the de rmis and then into th e circ lJl ~lto l'Y systenl, 
thereby rendering them undetectable in epidermal sampl es. 
In summary, although numero lls pathwa ys arc ~vai l a blc fo r 
f-ROL m etabolism in skin, retin yl ester form<1tion is the primary 
ro ute fOJ: disposition of phannacologic doses of t-ROL. T he final 
metaboli te that is the impo rtant retinoid for bio logic ac tivity in 
keratin ocytes, however , is I-RA . 
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